Madopar 50mg/12.5mg capsules Regatul Unit - engleză - MHRA (Medicines & Healthcare Products Regulatory Agency)

madopar 50mg/12.5mg capsules

roche products ltd - benserazide hydrochloride; levodopa - oral capsule - 12.5mg ; 50mg

Madopar 200mg/50mg capsules Regatul Unit - engleză - MHRA (Medicines & Healthcare Products Regulatory Agency)

madopar 200mg/50mg capsules

roche products ltd - benserazide hydrochloride; levodopa - oral capsule - 50mg ; 200mg

Madopar 50mg/12.5mg dispersible tablets Regatul Unit - engleză - MHRA (Medicines & Healthcare Products Regulatory Agency)

madopar 50mg/12.5mg dispersible tablets

roche products ltd - benserazide hydrochloride; levodopa - dispersible tablet - 12.5mg ; 50mg

Madopar 100mg/25mg dispersible tablets Regatul Unit - engleză - MHRA (Medicines & Healthcare Products Regulatory Agency)

madopar 100mg/25mg dispersible tablets

roche products ltd - benserazide hydrochloride; levodopa - dispersible tablet - 25mg ; 100mg

MADOPAR ROCHE 125 CAPSULE Malaezia - engleză - NPRA (National Pharmaceutical Regulatory Agency, Bahagian Regulatori Farmasi Negara)

madopar roche 125 capsule

roche (malaysia) sdn. bhd. - benserazide hydrochloride; levodopa -

Prolopa 250 200 mg - 50 mg tabl. Belgia - olandeză - AFMPS (Agence Fédérale des Médicaments et des Produits de Santé)

prolopa 250 200 mg - 50 mg tabl.

roche sa-nv - levodopa 200 mg; benserazidehydrochloride 57 mg - eq. benserazide 50 mg - tablet - 200 mg - 50 mg - levodopa 200 mg; benserazidehydrochloride 57 mg - levodopa and decarboxylase inhibitor

MADOPAR TAB (200+50)MG/TAB Grecia - greacă - Εθνικός Οργανισμός Φαρμάκων

madopar tab (200+50)mg/tab

roche hellas a.e Αλαμάνας 4 & Δελφών,, 151 25 151 25, Μαρούσι 61 66 100 - levodopa; benserazide hydrochloride - tab (ΔΙΣΚΙΟ) - (200+50)mg/tab - levodopa 200mg; benserazide hydrochloride 58mg - levodopa and decarboxylase inhibitor

Madopar 200 mg/50 mg hard capsules Irlanda - engleză - HPRA (Health Products Regulatory Authority)

madopar 200 mg/50 mg hard capsules

roche products (ireland) ltd - levodopa; benserazide - capsule, hard - 200 mg/50 milligram(s) - dopa and dopa derivatives; levodopa and decarboxylase inhibitor

Madopar Australia - engleză - Department of Health (Therapeutic Goods Administration)

madopar

roche products pty ltd - levodopa; benserazide hydrochloride; benserazide -

Madopar tablet (200/50) Australia - engleză - Department of Health (Therapeutic Goods Administration)

madopar tablet (200/50)

roche products pty ltd - benserazide hydrochloride, quantity: 57 mg (equivalent: benserazide, qty 50 mg); levodopa, quantity: 200 mg - tablet, uncoated - excipient ingredients: iron oxide red; crospovidone; colloidal anhydrous silica; microcrystalline cellulose; magnesium stearate; calcium hydrogen phosphate; mannitol; pregelatinised maize starch; docusate sodium; ethylcellulose - parkinson's disease and parkinsonian symptoms including post-encephalitic and toxic forms, but excluding drug induced parkinsonism.